FOR IMMEDIATE RELEASE
Functional Fluidics Presents Sickle Cell Disease Data from U.S. and Nigeria at ASH Conference in San Diego on December 7-10, 2024
Detroit, Michigan and..
Detroit, Michigan and Awka, Nigeria – June 5, 2024 /PRNewswire/ -- Functional Fluidics, a Detroit-based global health technology company specializing in red blood...
Functional Fluidics will present at two key scientific conferences in June to share crucial data aimed at advancing the development of better treatments for individuals with..
Exciting news! We’re a Michigan 50 Companies to Watch awardee! Since 2005, Michigan Celebrates Small Business has been recognizing businesses across all industries whose growth..
Patrick Hines, MD/PhD, will take the stage to share insights on the panel titled "Leveraging Emergent Technology for Export Excellence," an exploration into the dynamic..
Functional Fluidics is excited to present at the ASGCT 26th annual meeting, the premier event for professionals in gene and cell therapy
Functional Fluidics, a venture backed biotech company in Detroit, is building a global registry of sickle cell patient biomarker data to work with the Pharma industry on..
We're so excited that Walmart considered Functional Fluidics as a #BlackHealthHeroes to highlight during #BlackHistoryMonth. In this video, you’ll see other changemakers and..
Dr. Hines is internationally recognized for his efforts to develop and validate a gold standard for the Assessment of red blood cell health in clinical practice, work that grew..
“Dr. Daniel Kraft sat down with Dr. Patrick Hines, founder and CEO at Functional Fluidics, one of the nation’s leading sickle cell disease researchers at Wayne State University..
Session Overview: What are the barriers to translation of microfluidic assays as diagnostic/biomarker assays, companion diagnostics and/or clinical end points? How can we adapt..
#38 - You Bet Your Assay: A New Lab Test for Sickle Cell Disease Functional Fluidics CEO & Founder, Patrick Hines, sits down with Michael Callaghan, and Ahmar Urooj Zaidi, MD..
DETROIT, Mich., Feb. 16, 2021– Functional Fluidics recently participated in a pivotal study that indicates their biomarkers of red blood cell health can help define and predict..
Functional Fluidics' featured Sickle Cell Disease articles & news stories:
The international Sickle Cell World Assessment Survey (SWAY) aimed to provide insights into..
Functional Fluidics' featured Sickle Cell Disease articles & news stories:
“Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a..
Functional Fluidics CEO & Founder, Patrick Hines, will be the Scientific Keynote Speaker at the 15th Annual Sickle Cell Disease Research & Educational Symposium & 44th National..
Patrick Hines, Founder & CEO of Functional Fluidics, will be presenting at the 2021 Children’s National Sickle Cell Research Seminar Series about the exciting work the team at..
Join an expert panel of clinicians and scientists as they discuss insights from the Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS), a pivotal study..
“Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced it has entered into an agreement with Sanofi S.A. to exclusively in-license worldwide rights to two..
Oxbryta would be the first treatment targeting the root cause of SCD, hemolytic anemia, to be approved in the EU.
Global Blood Therapeutics , Inc. (GBT) (NASDAQ: GBT) today..
The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected to pose little risk to the rare disease..
A study in the journal, Blood, explains how the peptide Ac2-26 flips a biological switch in immune cells in people with Sickle Cell Disease.
Scientists have found a way to lower..
Sickle cell disease has a devastating impact on the lives of patients and their families, including serious and life-threatening complications that can lead to organ damage and..
Patients with sickle cell disease who are undernourished report higher disease severity and lower health-related quality of life scores.
A team, led by Sanaa Kamal, Prince..
Functional Fluidics participated in a groundbreaking study involving sickle cell patients
Hemolytic Biomarkers Predict Adhesiveness of Sickle Blood Cells in a Clinical Adhesion..
Functional Fluidics CEO & Founder, Patrick Hines, presenting "“The Science and Clinical Applications of Red Blood Cell Health in Sickle Cell Disease, COVID-19 and Beyond” as part..
Every hero has their own heroes.
So, as part of the 2020 Health Care Leadership Summit, we asked this year's class of Health Care Heroes award winners to share something about..
